Compare LSTA & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LSTA | RBOT |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | 131 |
| Industry | Misc Health and Biotechnology Services | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9M | 16.1M |
| IPO Year | N/A | N/A |
| Metric | LSTA | RBOT |
|---|---|---|
| Price | $2.02 | $2.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $23.50 | $7.00 |
| AVG Volume (30 Days) | 23.4K | ★ 159.3K |
| Earning Date | 11-06-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,070,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.81 | $2.36 |
| 52 Week High | $4.20 | $18.97 |
| Indicator | LSTA | RBOT |
|---|---|---|
| Relative Strength Index (RSI) | 45.08 | 30.74 |
| Support Level | $1.97 | $2.36 |
| Resistance Level | $2.15 | $2.58 |
| Average True Range (ATR) | 0.12 | 0.32 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 51.87 | 2.78 |
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port. The company has following segment: Research and development, Sales and marketing, General and administrative.